Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,593 | -7,544 | -22,046 | -17,127 | -11,743 |
| Depreciation Amortization | 1,470 | 661 | 2,136 | 1,508 | 1,042 |
| Accounts receivable | 409 | 335 | -179 | 91 | 66 |
| Other Working Capital | -187 | -171 | -772 | -730 | -731 |
| Other Operating Activity | 2,046 | 1,892 | 1,328 | 886 | 631 |
| Operating Cash Flow | $-9,855 | $-4,827 | $-19,533 | $-15,372 | $-10,735 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95 | -5 | 64 | -110 | -105 |
| Purchase Sale Intangibles | -1,201 | -1,158 | N/A | N/A | N/A |
| Other Investing Activity | -1,201 | -1,158 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,296 | $-1,163 | $64 | $-110 | $-105 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,540 | -1,770 | N/A | 0 | 0 |
| Common Stock Issued | 11,225 | 1,435 | 21,467 | 17,702 | 18,179 |
| Other Financing Activity | 0 | 0 | -3,858 | -1,774 | -1,774 |
| Financing Cash Flow | $7,685 | $-335 | $17,609 | $15,928 | $16,405 |
| Exchange Rate Effect | 13 | 20 | 82 | 140 | 139 |
| Beginning Cash Position | 12,910 | 12,910 | 14,338 | 14,338 | 14,338 |
| End Cash Position | 9,457 | 6,605 | 12,560 | 14,924 | 20,042 |
| Net Cash Flow | $-3,453 | $-6,305 | $-1,778 | $586 | $5,704 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,855 | -4,827 | -19,533 | -15,372 | -10,735 |
| Capital Expenditure | -95 | -5 | -67 | -110 | -105 |
| Free Cash Flow | -9,950 | -4,832 | -19,600 | -15,482 | -10,840 |